VTL stock forecast
Our latest prediction for Immunic, Inc.'s stock price was made on the Sept. 17, 2018 when the stock price was at 0.25$.
In the short term (2weeks), VTL's stock price should underperform the market by -0.44%. During that period the price should oscillate between -12.53% and +43.38%.
In the medium term (3months), VTL's stock price should outperform the market by 6.17%. During that period the price should oscillate between -24.91% and +119.75%.Get email alerts
Create a solid portfolio with VTL
About Immunic, Inc.
Develops pharmaceuticals and oral therapies for the treatment of chronic inflammatory and autoimmune diseases
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -1.27$ per share.
The book value per share is 0.62$
Three months stock forecastSept. 17, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|